Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
SOR-007 by Nanology for Small-Cell Lung Cancer: Likelihood of Approval
SOR-007 is under clinical development by Nanology and currently in Phase II for Small-Cell Lung Cancer. According to GlobalData, Phase...
SOR-007 by Nanology for Metastatic Adenocarcinoma of The Pancreas: Likelihood of Approval
SOR-007 is under clinical development by Nanology and currently in Phase II for Metastatic Adenocarcinoma of The Pancreas. According to...
Docetaxel by Nanology for Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer): Likelihood of Approval
Docetaxel is under clinical development by Nanology and currently in Phase II for Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial...
Docetaxel by Nanology for Transitional Cell Carcinoma (Urothelial Cell Carcinoma): Likelihood of Approval
Docetaxel is under clinical development by Nanology and currently in Phase II for Transitional Cell Carcinoma (Urothelial Cell Carcinoma). According...
Docetaxel by Nanology for Muscle Invasive Bladder Cancer (MIBC): Likelihood of Approval
Docetaxel is under clinical development by Nanology and currently in Phase II for Muscle Invasive Bladder Cancer (MIBC). According to...